文献速递胸部肿瘤放疗

小细胞肺癌中常规H&E切片评估的肿瘤浸润淋巴细胞的临床意义

Clinical significance of tumor-infiltrating lymphocytes investigated using routine H&E slides in small cell lung cancer.
PubMed 文献 · Radiat Oncol · 2022-07-18

该回顾性研究纳入2013年1月至2019年10月在本癌症中心治疗的159例小细胞肺癌患者,由两名病理医师独立重新评估常规H&E染色切片上的肿瘤浸润淋巴细胞(H&E-sTILs),分析其与总生存(OS)、无进展生存(PFS)和脑转移无生存(BMFS)的关系。结果显示H&E-sTILs阳性组3年OS、PFS和BMFS率均高于阴性组,多因素分析提示H&E-sTILs是影响OS和PFS的独立因素,且是BMFS的唯一危险因素;作者认为H&E-sTILs或可作为影响治疗短期反应的预后生物标志物,但需进一步前瞻性研究证实。

要点

  • H&E-sTILs阳性组3年OS率25.1% vs 阴性组5.1%(P=0.030)。
  • H&E-sTILs阳性组3年PFS率14.0% vs 阴性组4.0%(P=0.013)。
  • H&E-sTILs阳性组3年BMFS率66.0% vs 阴性组11.4%(P=0.023)。

核心结论

  • 作者认为H&E-sTILs或可作为影响治疗短期反应的预后生物标志物,并且是BMFS的唯一危险因素。
  • 作者指出,由于回顾性设计以及基于H&E染色切片视觉评估TILs的不足,需进一步前瞻性研究证实这些结论。

研究设计与样本

  • 回顾性研究,收集2013年1月至2019年10月在本癌症中心治疗的SCLC患者临床资料。
  • 共纳入159例符合纳入标准的SCLC患者,由两名经验丰富的病理医师独立重新评估H&E-sTILs。
  • 采用Kaplan-Meier法和log-rank检验分析H&E-sTILs对OS、PFS和BMFS的影响,随后用Cox比例风险模型进行多因素分析。

主要发现

  • 全组1年、2年和3年OS率分别为59.8%、28.6%和19.8%。
  • H&E-sTILs阳性组与阴性组3年OS率分别为25.1%与5.1%(P=0.030)。
  • H&E-sTILs阳性组与阴性组3年PFS率分别为14.0%与4.0%(P=0.013)。
  • H&E-sTILs阳性组与阴性组3年BMFS率分别为66.0%与11.4%(P=0.023)。
  • 多因素分析显示,H&E-sTILs、临床M分期、化疗周期数和胸部放疗短期反应是影响OS的独立因素;H&E-sTILs、临床N分期、临床M分期和化疗短期反应是影响PFS的因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出回顾性设计存在局限性。
  • 原文指出基于H&E染色切片视觉评估TILs存在不足。
  • 原文结论提出需进一步前瞻性研究证实这些结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tumor-infiltrating lymphocytes (TILs), investigated using routine hematoxylin and eosin (H&E)-stained section slides (H&E-sTILs), provide a robust prognostic biomarker in various types of solid cancer. The purpose of the present study was to investigate the prognostic significance of H&E-sTILs in patients with small cell lung cancer (SCLC). METHODS: The clinical data of patients with SCLC who had been treated in our cancer center between January 2013 and October 2019 were collected and retrospectively reviewed. The H&E-sTILs were re-assessed by two experienced pathologists independently. H&E-sTILs that affected the overall survival (OS), progression free survival (PFS) and brain-metastasis free survival (BMFS) rates were explored using the Kaplan-Meier method, and the log-rank test was used to assess the differences. Multivariate analysis was subsequently performed using the Cox proportion hazards model. RESULTS: A total of 159 patients with SCLC who fulfilled the inclusion criteria were enrolled in the current study. The OS rates at 1, 2 and 3 years were 59.8, 28.6 and 19.8%, respectively, for the whole group. The 3-year OS, PFS and BMFS rates for the H&E-sTILs(+) and H&E-sTILs(-) groups were 25.1% cf. 5.1% (P = 0.030), 14.0% cf. 4.0% (P = 0.013), and 66.0% cf. 11.4% (P = 0.023), respectively. Multivariate analyses subsequently revealed that H&E-sTILs, clinical M stage, the cycles of chemotherapy and short-term response to thoracic radiotherapy were independent factors affecting OS, whereas H&E-sTILs, clinical N stage, clinical M stage and short-term response to chemotherapy were factors affecting PFS. The H&E-sTILs affected OS, PFS and BMFS simultaneously. CONCLUSIONS: The results of this retrospective study have shown that H&E-sTILs may be considered as a prognostic biomarker affecting the short-term response to treatment, and they are the one and only risk factor for BMFS. However, due to the limitations of the nature of the retrospective design and shortcomings in visually assessing the TILs based on the H&E-stained slides, further prospective studies are required to confirm these conclusions.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Zhou G, Zheng J, Chen Z, et al. Clinical significance of tumor-infiltrating lymphocytes investigated using routine H&E slides in small cell lung cancer. Radiat Oncol. 2022. PMID: 35850908. doi:10.1186/s13014-022-02098-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。